188 related articles for article (PubMed ID: 29133472)
1. Rheumatic Heart Disease Treatment Cascade in Uganda.
Longenecker CT; Morris SR; Aliku TO; Beaton A; Costa MA; Kamya MR; Kityo C; Lwabi P; Mirembe G; Nampijja D; Rwebembera J; Sable C; Salata RA; Scheel A; Simon DI; Ssinabulya I; Okello E
Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29133472
[TBL] [Abstract][Full Text] [Related]
2. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.
Voleti S; Okello E; Murali M; Sarnacki R; Majwala A; Ssembatya R; Bakka O; Namisanvu H; Njeri A; Matovu A; DeStigter K; Sable C; Beaton A
BMC Pregnancy Childbirth; 2020 Oct; 20(1):611. PubMed ID: 33036571
[TBL] [Abstract][Full Text] [Related]
3. Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation.
Okello E; Longenecker CT; Beaton A; Kamya MR; Lwabi P
BMC Cardiovasc Disord; 2017 Jan; 17(1):20. PubMed ID: 28061759
[TBL] [Abstract][Full Text] [Related]
4. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
[TBL] [Abstract][Full Text] [Related]
5. Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.
Beaton A; Aliku T; Dewyer A; Jacobs M; Jiang J; Longenecker CT; Lubega S; McCarter R; Mirabel M; Mirembe G; Namuyonga J; Okello E; Scheel A; Tenywa E; Sable C; Lwabi P
Circulation; 2017 Dec; 136(23):2233-2244. PubMed ID: 28972003
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and Care Quality Metrics for Women of Reproductive Age Living With Rheumatic Heart Disease in Uganda.
Chang AY; Nabbaale J; Okello E; Ssinabulya I; Barry M; Beaton AZ; Webel AR; Longenecker CT
J Am Heart Assoc; 2020 Apr; 9(8):e015562. PubMed ID: 32295465
[TBL] [Abstract][Full Text] [Related]
7. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening.
Culliford-Semmens N; Tilton E; Webb R; Lennon D; Paku B; Malcolm J; French S; Blair N; Wilson N
N Z Med J; 2017 Jun; 130(1457):50-57. PubMed ID: 28617789
[TBL] [Abstract][Full Text] [Related]
8. Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India.
Arvind B; Saxena A; Kazi DS; Bolger AF
Indian Heart J; 2021; 73(2):169-173. PubMed ID: 33865513
[TBL] [Abstract][Full Text] [Related]
9. Health system and patient-level factors serving as facilitators and barriers to rheumatic heart disease care in Sudan.
Edwards JG; Barry M; Essam D; Elsayed M; Abdulkarim M; Elhossein BMA; Mohammed ZHA; Elnogomi A; Elfaki ASE; Elsayed A; Chang AY
Glob Health Res Policy; 2021 Oct; 6(1):35. PubMed ID: 34598719
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes, Echocardiographic Findings, and Care Quality Metrics for People Living With Human Immunodeficiency Virus (HIV) and Rheumatic Heart Disease in Uganda.
Chang AY; Rwebembera J; Bendavid E; Okello E; Barry M; Beaton AZ; Haeffele C; Webel AR; Kityo C; Longenecker CT
Clin Infect Dis; 2022 May; 74(9):1543-1548. PubMed ID: 34382644
[TBL] [Abstract][Full Text] [Related]
11. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
Liaw J; Gorton S; Heal C; White A
Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
[TBL] [Abstract][Full Text] [Related]
12. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
[TBL] [Abstract][Full Text] [Related]
13. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
[TBL] [Abstract][Full Text] [Related]
14. Adherence to Benzathine Penicillin G Secondary Prophylaxis and Its Determinants in Patients with Rheumatic Heart Disease at a Cardiac Center of an Ethiopian Tertiary Care Teaching Hospital.
Mekonen KK; Yismaw MB; Abiye AA; Tadesse TA
Patient Prefer Adherence; 2020; 14():343-352. PubMed ID: 32110000
[TBL] [Abstract][Full Text] [Related]
15. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
[TBL] [Abstract][Full Text] [Related]
16. The clinical characteristics of adults with rheumatic heart disease in Yangon, Myanmar: An observational study.
Myint NPST; Aung NM; Win MS; Htut TY; Ralph AP; Cooper DA; Nyein ML; Kyi MM; Hanson J
PLoS One; 2018; 13(2):e0192880. PubMed ID: 29466408
[TBL] [Abstract][Full Text] [Related]
17. Rheumatic Heart Disease in the United States: Forgotten But Not Gone: Results of a 10 Year Multicenter Review.
de Loizaga SR; Arthur L; Arya B; Beckman B; Belay W; Brokamp C; Hyun Choi N; Connolly S; Dasgupta S; Dibert T; Dryer MM; Gokanapudy Hahn LR; Greene EA; Kernizan D; Khalid O; Klein J; Kobayashi R; Lahiri S; Lorenzoni RP; Otero Luna A; Marshall J; Millette T; Moore L; Muhamed B; Murali M; Parikh K; Sanyahumbi A; Shakti D; Stein E; Shah S; Wilkins H; Windom M; Wirth S; Zimmerman M; Beck AF; Ollberding N; Sable C; Beaton A
J Am Heart Assoc; 2021 Aug; 10(16):e020992. PubMed ID: 34348475
[TBL] [Abstract][Full Text] [Related]
18. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease.
Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of Indian children enrolled in a rheumatic heart disease registry.
Mehta A; Saxena A; Juneja R; Ramakrishnan S; Gupta S; Kothari SS
Int J Cardiol; 2016 Nov; 222():1136-1140. PubMed ID: 27567391
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics, Complications, and Treatment Practices in Patients With RHD: 6-Year Results From HP-RHD Registry.
Negi PC; Mahajan K; Rana V; Sondhi S; Mahajan N; Rathour S; Verma R; Dhiman A; Dev M; Rao S; Asotra S; Bhardwaj R; Ganju N; Kandoria A; Merwaha R; Sharma R; Kolte N; Kumar V R; Paul PK; Singh DP
Glob Heart; 2018 Dec; 13(4):267-274.e2. PubMed ID: 30197242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
